Close button
Enquiry IconContact Us
Logo
  • Choose License Type

Global Parenteral Nutrition Market, by Nutrition Type (Carbohydrates, Lipid Emulsion, Amino Acid Solutions, Electrolytes, Vitamins and Trace Minerals, and Others), by Patient Type (Infants, Adults, and Geriatric), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 4,133.6 million in 2021, and is expected to exhibit a CAGR of 5.2% during the forecast period (2021-2028).

Increasing number of product launches or approvals is expected to help in boosting growth of the global parenteral nutrition market. For instance, in January 2020, American Regent Inc., a Daiichi Sankyo Group company, announced that it received the U.S. Food & Drug Administration (FDA) approval for Zinc Sulfate Injection, USP. Zinc Sulfate is a trace element indicated in adult and pediatric patients as a source of zinc for parenteral nutrition.

Increase in number of acquisitions, partnerships, and collaborations between market players is expected to propel the growth of the global parenteral nutrition market during the forecast period. For instance, in June 2017, Eurolife Healthcare Pvt. Ltd., a leading pharmaceutical company, acquired Baxter's intravenous (I.V.) fluid business in India, with its manufacturing locations in Aurangabad and Chennai. It offers quality products from manufacturing plants, continuing the 100% bench-marking quality assurance of parenteral nutrition products.

Global Parenteral Nutrition Market- Impact of Coronavirus (COVID – 19) Pandemic

The COVID-19 pandemic has affected several markets such as elective surgeries, dermatology across the globe. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets.

However, during the pandemic, key players in the global parenteral nutrition market were focused on expansion of manufacturing facilities for the production of parenteral nutrition products, where the prevalence of nutritional deficiency is high. This is expected to increase the growth of the global parenteral nutrition market over the forecast period. For instance, on June 3, 2021, Pharmasyntez, a pharmaceutical company headquartered in Russia, announced that the company is planning for the construction of new manufacturing facility in the Kalgua region, Russia. The company invested approximately US$ 0.028 billion in the manufacturing of new facility. This new manufacturing facility is expected to produce approximately one million bottles of parenteral nutrition over a year.

Browse 37 Market Data Tables and 32 Figures spread through 224 Pages and in-depth TOC on Global Parenteral Nutrition Market, by Nutrition Type (Carbohydrates, Lipid Emulsion, Amino Acid Solutions, Electrolytes, Vitamins and Trace Minerals, and Others), by Patient Type (Infants, Adults, and Geriatric), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the global parenteral nutrition market, click the link below:

https://www.coherentmarketinsights.com/market-insight/parenteral-nutrition-market-4804

Key Takeaways of the Global Parenteral Nutrition Market:

  • The global parenteral nutrition market is expected to exhibit a CAGR of 5.2% over the forecast period (2021-2028). North America is expected to account for major market share over the forecast period (2021-2028), owing to the increasing collaborations by market players. For instance, in October 2018, Baxter International Inc., a pharmaceutical company, collaborated with the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition and launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organization’s ‘SmartPN’ collaboration to help reduce clinical malnutrition.
  • Some of the major players operating in the global parenteral nutrition market include Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Otsuka Pharmaceutical India Pvt. Ltd., Pfizer, Inc., Grifols, S.A., JW Pharmaceutical, Aculife Healthcare, Kelun, American Regent Inc., and Eurolife Healthcare Pvt. Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.